Page last updated: 2024-09-03

matairesinol and Sepsis

matairesinol has been researched along with Sepsis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Li, Q; Wang, Y; Wu, Q	1

Other Studies

1 other study(ies) available for matairesinol and Sepsis

Article	Year
Matairesinol exerts anti-inflammatory and antioxidant effects in sepsis-mediated brain injury by repressing the MAPK and NF-κB pathways through up-regulating AMPK. Aging, 2021, Oct-27, Volume: 13, Issue:20 Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Antioxidants; Brain; Brain Diseases; Cell Line; Disease Models, Animal; Furans; Lignans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; NF-kappa B; Rats; Sepsis; Up-Regulation	2021

Article

Year

Matairesinol exerts anti-inflammatory and antioxidant effects in sepsis-mediated brain injury by repressing the MAPK and NF-κB pathways through up-regulating AMPK.

Aging, 2021, Oct-27, Volume: 13, Issue:20

Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Antioxidants; Brain; Brain Diseases; Cell Line; Disease Models, Animal; Furans; Lignans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; NF-kappa B; Rats; Sepsis; Up-Regulation

2021